menu
    • menu

    Company profile for Teva Pharmaceutical Industries

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong glob...
    Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 3,500 medicines, and produce approximately 120 billion tablets and capsules a year at 70 manufacturing facilities. We rank among the leading pharmaceutical companies in the world and are active in 60 countries. Approximately 43,000 employees around the world are dedicated to our mission. Building on our strong global footprint, size and scale, Teva is reaffirming its commitment to place people at the center of our strategy, and enable as many as possible to live better, healthier days.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Teva Pharmaceutical IndustriesIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    5 Basel St., Petach Tikva Israel, 49131
    Telephone
    Telephone
    +972-3-9267267
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tevapharm.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/teva-pharmaceuticals/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    “LGM Pharma has made significant strides in meeting the evolving needs of its clients”

    This week, SpeakPharma interviews four senior executives of LGM Pharma — Shailesh Vengurlekar (Senior VP, Quality and Regulatory Affairs), Deepak Thassu (Senior VP, R&D and Regulatory Submission), Selwyn Lustman (Senior VP, Global Sourcing and Procurement), and Mike Stenberg (VP, Business Development). The four VPs talk about expansion in manufacturing capabilities of the Florida-based contract development and manufacturing organization (CDMO), expertise that makes LGM a strong partner and the criteria it adopts while selecting its suppliers.  HIGHLIGHTS// expansion in manufacturing capabilities/ expertise that makes LGM a strong partner/ criteria for selecting its suppliers LGM Pharma recently invested heavily in expanding its CDMO capabilities by 50 percent. Can you share why offering standalone analytical testing services is important to LGM Pharma’s growth strategy? How does it benefit your clients? Vengurlekar: This recent expansion in CDMO capabilities is part of LGM Pharma’s growth strategy that lays importance on diversification. One key area of this diversification is the offering of standalone Analytical Testing Services (ATS). This service plays a crucial role in supporting our clients by providing them with greater flexibility and reliability. LGM Pharma is already a well-established leader in the API supply chain. We have now identified a significant need in the market and are now serving compounding pharmacies, including 503A and 503B facilities. These pharmacies not only require high-quality, GMP-compliant APIs, but also need a trusted, compliant, and capable laboratory to analyze both their APIs and compounded products. Recognizing this opportunity to further support our clients, LGM Pharma has expanded into ATS. We have witnessed tremendous growth since we’ve launched these services. By offering ATS under a separate legal entity — LGM Pharma Solutions — we are able to provide an additional layer of flexibility to our clients. This structure eliminates any conflict of interest. While LGM Pharma LLC handles API supply, LGM Pharma Solutions focuses on delivering top-tier ATS, all under the same LGM Pharma umbrella. This setup enhances trust and allows our clients to work with us more seamlessly. HIGHLIGHTS// diversified into standalone ATS/ well-established leader in API supply chain/ serving compounding pharmacies/ offering APIs and ATS under different legal entities. While suppositories offer clear advantages for certain medications, can you describe how LGM Pharma plans to leverage its expertise in this area to address specific unmet needs in the growing women’s health market? Thassu: We’re taking a dual approach to enhance both our R&D and manufacturing capabilities. First, we’ve introduced a new semi-automatic machine that allows us to produce smaller batches more efficiently. This is particularly important for the suppository segment, where demand doesn’t require large-scale production. The new system enables quicker adjustments to the manufacturing process, providing us with greater flexibility of producing small batches. Second, many of the materials we handle in the women’s health sector are sensitive to heat, light, and oxygen. To address this, we’re upgrading our facility to accommodate these specialized requirements. This ensures we can develop and manufacture products while maintaining the integrity of heat-, light-, and oxygen-sensitive ingredients. Additionally, we’re working closely with clients to prepare for various technical challenges. Whether it’s processing homeopathic ingredients or handling delicate fermentation-based materials, which are highly sensitive to both light and heat, our team has upgraded its skills and equipment to manage these complexities. From technology advancements in manufacturing to specialized handling conditions and improved technical expertise, we’ve made significant strides to ensure we can meet the evolving needs of our clients and their products. HIGHLIGHTS// dual approach to enhance R&D and manufacturing capabilities/ upgrading facilities to accommodate specialized requirements/ working with clients to address challenges. The pandemic underscored supply chain problems. Can you detail the specific criteria LGM Pharma uses while selecting suppliers for its manufacturing processes? Lustman: LGM looks at many facets of a manufacturer before proceeding to approve them for a specific project. We start by checking their regulatory history with the US Food and Drug Administration (FDA) and other authorities. We try to find out if they have received any warning letters. What is their inspection history? Have they received NAIs (no action indicated) and VAIs (voluntary action indicated)? We further investigate the company’s overall business status — we need to know that they are a stable partner to work with in the long term. Manufacturers are then assessed for their overall technology and the number of employees working in various fields, such as R&D, quality control, quality assurance, regulatory affairs, manufacturing, and the educational levels of these employees. Once we have established that the manufacturer is a potential partner, we check their status for a particular project. We look at their advantages, and whether they have a non-infringing route of synthesis (ROS) that will allow early launch. Are they developing a second process that will be more competitive in pricing? And, does the manufacturer have the necessary capacity and/or spare capacity for the project that we are assessing? We need to know whether the drug master file (DMF) has been registered, the current batch size, and the potential for increase in batch size. Pricing is a key indicator — we need to know whether the pricing of the manufacturer is competitive or not, and if the manufacturer will be able to compete in the future as the project matures. LGM always assesses for quality, price, and delivery. Goods must be of the correct quality, at the right price, with delivery time as desired, in order to meet commercial needs. HIGHLIGHTS// investigate various facets of manufacturer before approving them for a project/ look at advantages, non-infringing ROS/ assess for quality, price, delivery Can you highlight specific capabilities and experiences LGM Pharma possesses that make it a strong partner for companies developing antibody-drug-conjugates (ADCs)? Stenberg: ADCs are often peptides linked with small molecules. However, they may also be peptides linked with oligonucleotides. Regardless, LGM can help manage the supply chain associated with the components that are used in the conjugation of the ADC. LGM has extensive experience, and an extensive network around sourcing and managing the supply chain associated with ADC components. LGM’s experience and capabilities extend to sourcing peptides, small molecules or oligonucleotides used in the conjugation process. Additionally, given our deep relationships in the supply chain aspect of this process, LGM may also be able to identify partners who can help with the conjugation process itself. HIGHLIGHTS// extensive experience, network around sourcing, managing supply chain associated with ADC components / identify partners that can help with conjugation process

    Impressions: 489

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients

    #SpeakPharma With LGM Pharma
    09 Nov 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    Medical Breakthroughs in 2024: Alzheimer’s, schizophrenia, COPD, MASH see pathbreaking treatments

    This year has seen pivotal advancements in medical innovation. The US Food and Drug Administration (FDA) has approved several groundbreaking therapies that promise to transform patient care across multiple therapeutic areas.Some of the therapies approved have revolutionary delivery mechanisms, while others are first-in-class treatments for previously unaddressed conditions. This week, PharmaCompass brings you a compilation of new pathbreaking approvals of 2024, including advancements in neurology, chronic conditions, mental health conditions, and innovative solutions for various other ailments.Lilly, Alpha Cognition, BMS transform neurological care with new Alzheimer’s, schizophrenia drugsThe neurological treatment landscape saw several major breakthroughs in 2024, particularly in the treatment of Alzheimer’s disease (AD). Eli Lilly’s Kisunla represents a significant advancement in treating early, symptomatic AD. Following decades of failed efforts, Kisunla’s approval, along with that of Eisai-Biogen’s Leqembi last year, marks a turning point in addressing AD.The drug works by targeting and clearing beta amyloid plaque from the brain, thereby attacking the disease’s underlying pathology, rather than just managing symptoms. Administered as an infusion every four weeks, Kisunla’s Medicare coverage makes it accessible to patients in the US who desperately need new treatment options. Alpha Cognition’s Zunveyl emerged as a promising new oral treatment for mild-to-moderate Alzheimer’s-related dementia. Only the second oral AD treatment approved by the FDA in over a decade, Zunveyl is a prodrug, or a biologically inactive compound that can be metabolized by the body to produce a drug. It remains inactive as it passes through the stomach and enhances cholinergic function in the brain.Perhaps one of the most exciting breakthroughs of 2024 was Bristol-Myers Squibb’s Cobenfy. This revolutionary antipsychotic medication for schizophrenia represents the first novel approach to treatment since the 1950s. Unlike traditional antipsychotics that target dopamine receptors, Cobenfy works through cholinergic receptors, offering new hope to patients who struggle with the side effects of conventional treatments.Traditional antipsychotics have been associated with several mild and serious side effects such as weight gain, feeling unmotivated and sluggish, high rates of cardiac disease, and even early death. Cobenfy’s innovative mechanism of action has generated excitement in the medical community. Experts project Cobenfy to bring in US$ 7.5 billion in peak annual sales, thereby validating BMS’ recent, US$ 14-billion acquisition of Karuna Therapeutics.Verona, Sanofi’s drugs revolutionize COPD care; Madrigal’s Rezdiffra offers hope to MASH patients The landscape of chronic obstructive pulmonary disease (COPD) treatment saw remarkable advances in 2024. Verona Pharma’s Ohtuvayre brings the first new mechanism of action in over two decades for COPD treatment. This dual-action, inhaled medication serves as both a bronchodilator and an anti-inflammatory agent, offering a comprehensive approach to symptom management.Adding to this progress, Sanofi and Regeneron’s Dupixent achieved a historic milestone by becoming the first biologic approved for treating COPD. Dupixent is Sanofi’s best-selling drug. It is poised to cross over € 21 billion (US$ 23.5 billion) in sales by 2030, with COPD likely to contribute US$ 2.9 billion, predict analysts. Over 390 million people are living with COPD worldwide.In the field of liver disease, Madrigal Pharmaceuticals’ Rezdiffra became the first FDA-approved treatment for metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring. This approval represents a breakthrough in a field that has been notorious for being a graveyard for failed programs. Rezdiffra offers hope to patients with this common liver condition, which primarily affects those with obesity or type 2 diabetes. The American Liver Foundation has termed this approval a “game-changing” moment in hepatology.For the rare disease community, Ipsen’s Iqirvo emerged as the first new medicine approved in nearly a decade for primary biliary cholangitis (PBC). This first-in-class peroxisome proliferator-activated receptor (PPAR) agonist offers new hope for the approximately 100,000 Americans affected by this condition, particularly women aged 30 to 60 years.A significant breakthrough for patients with hypoparathyroidism came with the approval of Ascendis’ Yorvipath, making it the only treatment for hypoparathyroidism in adults. By directly addressing the underlying hormone deficiency, Yorvipath helps stabilize calcium levels in the blood, reducing the treatment burden associated with managing symptoms through calcium and vitamin D supplements alone.In the realm of pulmonary medicine, Merck’s Winrevair emerged as the first new therapy for pulmonary arterial hypertension (PAH) in over a decade. As the first approved activin-signaling inhibitor therapy, Winrevair represents a novel approach to treating this rare but severe condition that doctors call a “ticking time bomb”. The drug is the first treatment that targets the underlying cause of the lung condition, which typically leads to death within a decade of diagnosis.ARS Pharma launches nasal spray alternative to EpiPen, Eicos introduces med for severe frostbiteLeading the charge in innovative drug delivery is ARS Pharma’s Neffy, the first-ever nasal spray alternative to the EpiPen for treating severe allergic reactions. This groundbreaking advancement represents the first major innovation in anaphylaxis treatment in over a decade. For children and individuals with needle phobia, this nasal spray format addresses one of the most significant barriers to timely treatment of allergic emergencies. Speaking of emergency medicine, Eicos Sciences’ Aurlumyn made history as the first FDA-approved treatment for severe frostbite. This approval fills a critical gap in emergency care, offering a medical intervention that could prevent the need for amputation in severe cases.The cardiovascular space saw its first oral anti-hypertensive therapy that works through a new therapeutic pathway in almost 40 years. Idorsia’s Tryvio is a treatment for hypertension that offers new hope to patients whose blood pressure remains inadequately controlled on existing medications. Idorsia expects millions of patients to benefit from it.Our view This year, the pharmaceutical industry has taken a remarkable leap forward by addressing some of healthcare’s most challenging conditions. Treatments like BMS’ Cobenfy for schizophrenia and Madrigal’s Rezdiffra for MASH demonstrate the industry’s growing ability to translate science into practical therapies. With the growing use of artificial intelligence in the drug industry, we hope that these approvals are just a precursor to a bevy of pathbreaking therapies in the years to come. 
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 680

    https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

    #Phispers by PHARMACOMPASS
    14 Nov 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Teva to Present at the Jefferies London Healthcare Conference
    Teva to Present at the Jefferies London Healthcare Conference

    08 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/08/2977888/0/en/Teva-to-Present-at-the-Jefferies-London-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Nov 2024
    Share Share
    Hefty sales of generics boost Teva to another big quarter
    Hefty sales of generics boost Teva to another big quarter

    07 Nov 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/tevas-generics-and-biosimilars-fuel-another-booming-quarter

    FIERCE PHARMA
    07 Nov 2024
    Share Share
    Teva Pharma`s Generics Fedratinib Receives Tentative Approval in US
    Teva Pharma`s Generics Fedratinib Receives Tentative Approval in US

    07 Nov 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218907

    FDA
    07 Nov 2024
    Share Share
    Teva Pharmaceutical sees more growth in 2025 after strong Q3
    Teva Pharmaceutical sees more growth in 2025 after strong Q3

    06 Nov 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/teva-pharmaceutical-third-quarter-profit-revenue-top-estimates-2024-11-06/

    REUTERS
    06 Nov 2024
    Share Share
    Teva Pharm CEO says will work productively with Trump
    Teva Pharm CEO says will work productively with Trump

    06 Nov 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/teva-pharm-ceo-says-will-work-productively-with-trump-administration-2024-11-06/

    REUTERS
    06 Nov 2024
    Share Share
    Teva Reports Strong Q3 2024 Results, Raises Financial Outlook
    Teva Reports Strong Q3 2024 Results, Raises Financial Outlook

    06 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/06/2975550/0/en/Teva-Announces-Strong-Financial-Results-for-the-Third-Quarter-of-2024-led-by-Generics-Performance-and-Innovative-Portfolio-Growth-Raises-2024-Financial-Outlook-including-on-Revenue.html

    GLOBENEWSWIRE
    06 Nov 2024
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Alvotech And Teva Gain FDA Approval for SELARSDI Label Expansion

    Details:

    Selarsdi (ustekinumab) is a monoclonal antibody, binds to two cytokines, IL-12 and IL-23, that are involved in inflammatory and immune responses. It is approved for treating ulcerative colitis.


    Lead Product(s): Ustekinumab

    Therapeutic Area: Gastroenterology Brand Name: Selarsdi

    Study Phase: ApprovedProduct Type: Large molecule

    Recipient: Alvotech

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 22, 2024

    blank

    01

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Ustekinumab

    Therapeutic Area : Gastroenterology

    Highest Development Status : Approved

    Recipient : Alvotech

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Alvotech And Teva Gain FDA Approval for SELARSDI Label Expansion

    Details : Selarsdi (ustekinumab) is a monoclonal antibody, binds to two cytokines, IL-12 and IL-23, that are involved in inflammatory and immune responses. It is approved for treating ulcerative colitis.

    Brand Name : Selarsdi

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    October 22, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Prolia® Biosimilar Candidate Accepted For Review by FDA & EMA

    Details:

    TVB-009P(denosumab) is a biosimilar candidate to Prolia, which is being developed for the high risk for fracture, such as osteoporosis in postmenopausal women.


    Lead Product(s): Denosumab

    Therapeutic Area: Musculoskeletal Brand Name: TVB-009P

    Study Phase: Phase IIIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 08, 2024

    blank

    02

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Denosumab

    Therapeutic Area : Musculoskeletal

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Prolia® Biosimilar Candidate Accepted For Review by FDA & EMA

    Details : TVB-009P(denosumab) is a biosimilar candidate to Prolia, which is being developed for the high risk for fracture, such as osteoporosis in postmenopausal women.

    Brand Name : TVB-009P

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    October 08, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Deals
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Expands Partnership with mAbxience for Additional Oncology Biosimilar

    Details:

    mAbxience will lead the development and production of an anti PD-1 biosimilar and Teva will manage regulatory approvals and oversee commercialization of this oncology treatment.


    Lead Product(s): Anti PD-1-based Therapy

    Therapeutic Area: Oncology Brand Name: Undisclosed

    Study Phase: UndisclosedProduct Type: Large molecule

    Sponsor: Mabxience

    Deal Size: Undisclosed Upfront Cash: Undisclosed

    Deal Type: Partnership October 03, 2024

    blank

    03

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Anti PD-1-based Therapy

    Therapeutic Area : Oncology

    Highest Development Status : Undisclosed

    Partner/Sponsor/Collaborator : Mabxience

    Deal Size : Undisclosed

    Deal Type : Partnership

    DEALS_DEV arrow-down

    Teva Expands Partnership with mAbxience for Additional Oncology Biosimilar

    Details : mAbxience will lead the development and production of an anti PD-1 biosimilar and Teva will manage regulatory approvals and oversee commercialization of this oncology treatment.

    Brand Name : Undisclosed

    Molecule Type : Large molecule

    Upfront Cash : Undisclosed

    October 03, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Launches First Generic Version of Sandostatin® LAR Depot in The U.S.

    Details:

    Sandostatin-Generic (octreotide acetate) is a somatostatin analogue peptide, which is being evaluated for the treatment of acromegaly, carcinoid tumors & vasoactive intestinal peptide tumors.


    Lead Product(s): Octreotide Acetate

    Therapeutic Area: Endocrinology Brand Name: Sandostatin-Generic

    Study Phase: ApprovedProduct Type: Peptide

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable October 01, 2024

    blank

    04

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Octreotide Acetate

    Therapeutic Area : Endocrinology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Launches First Generic Version of Sandostatin® LAR Depot in The U.S.

    Details : Sandostatin-Generic (octreotide acetate) is a somatostatin analogue peptide, which is being evaluated for the treatment of acromegaly, carcinoid tumors & vasoactive intestinal peptide tumors.

    Brand Name : Sandostatin-Generic

    Molecule Type : Peptide

    Upfront Cash : Not Applicable

    October 01, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Shows Long-Term Safety of Deutetrabenazine For Tardive Dyskinesia

    Details:

    FDA has approved Teva's AUSTEDO XR (deutetrabenazine,vmat2 inhibitor) extended-release tablets as a once-daily treatment option for adults with tardive dyskinesia and Huntington’s disease chorea.


    Lead Product(s): Deutetrabenazine

    Therapeutic Area: Neurology Brand Name: Austedo

    Study Phase: ApprovedProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable September 23, 2024

    blank

    05

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Deutetrabenazine

    Therapeutic Area : Neurology

    Highest Development Status : Approved

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Shows Long-Term Safety of Deutetrabenazine For Tardive Dyskinesia

    Details : FDA has approved Teva's AUSTEDO XR (deutetrabenazine,vmat2 inhibitor) extended-release tablets as a once-daily treatment option for adults with tardive dyskinesia and Huntington’s disease chorea.

    Brand Name : Austedo

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    September 23, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Presents Phase 3 Data on TEV-‘749 as Long-Acting Injectable for Schizophrenia

    Details:

    TEV-‘749 is being developed as a once-monthly subcutaneous LAI of olanzapine with the use of SteadyTeq™ technology, a copolymer technology for the treatment of adults with schizophrenia.


    Lead Product(s): Olanzapine

    Therapeutic Area: Psychiatry/Psychology Brand Name: TEV-‘749

    Study Phase: Phase IIIProduct Type: Small molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable September 21, 2024

    blank

    06

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Olanzapine

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Presents Phase 3 Data on TEV-‘749 as Long-Acting Injectable for Schizophrenia

    Details : TEV-‘749 is being developed as a once-monthly subcutaneous LAI of olanzapine with the use of SteadyTeq™ technology, a copolymer technology for the treatment of adults with schizophrenia.

    Brand Name : TEV-‘749

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    September 21, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Updates on Pivotal Phase 3 Trial of Olanzapine Long-Acting Injectable

    Details:

    TEV-‘749 is being developed as a once-monthly subcutaneous LAI of olanzapine with the use of SteadyTeq™ technology, a copolymer technology for the treatment of adults with schizophrenia.


    Lead Product(s): Olanzapine

    Therapeutic Area: Psychiatry/Psychology Brand Name: TEV-‘749

    Study Phase: Phase IIIProduct Type: Small molecule

    Sponsor: MedinCell

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable September 05, 2024

    blank

    07

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Olanzapine

    Therapeutic Area : Psychiatry/Psychology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : MedinCell

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Updates on Pivotal Phase 3 Trial of Olanzapine Long-Acting Injectable

    Details : TEV-‘749 is being developed as a once-monthly subcutaneous LAI of olanzapine with the use of SteadyTeq™ technology, a copolymer technology for the treatment of adults with schizophrenia.

    Brand Name : TEV-‘749

    Molecule Type : Small molecule

    Upfront Cash : Not Applicable

    September 05, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A in Bowel Disease

    Details:

    TEV-’574 (duvakitug) is a potential best-in-class human IgG1-lambda 2 mAb that targets tumor necrosis factor (TNF)-like ligand 1A, also known as TNF superfamily member 15 (TNFSF15).


    Lead Product(s): Duvakitug

    Therapeutic Area: Gastroenterology Brand Name: TEV-48574

    Study Phase: Phase IIProduct Type: Large molecule

    Sponsor: Sanofi

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 24, 2024

    blank

    08

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Duvakitug

    Therapeutic Area : Gastroenterology

    Highest Development Status : Phase II

    Partner/Sponsor/Collaborator : Sanofi

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A in Bowel Disease

    Details : TEV-’574 (duvakitug) is a potential best-in-class human IgG1-lambda 2 mAb that targets tumor necrosis factor (TNF)-like ligand 1A, also known as TNF superfamily member 15 (TNFSF15).

    Brand Name : TEV-48574

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    July 24, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Touts First CGRP Success in Phase III Paediatric Migraine Prevention Study

    Details:

    Ajovy (fremanezumab) a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in 6-17 years patients.


    Lead Product(s): Fremanezumab

    Therapeutic Area: Neurology Brand Name: Ajovy

    Study Phase: Phase IIIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 19, 2024

    blank

    09

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Fremanezumab

    Therapeutic Area : Neurology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Touts First CGRP Success in Phase III Paediatric Migraine Prevention Study

    Details : Ajovy (fremanezumab) a FDA approved, humanized mAb which selectively binds the calcitonin gene-related peptide (CGRP). It is being investigated for the prevention of migraine in 6-17 years patients.

    Brand Name : Ajovy

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    July 19, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Teva Announces Phase 3 Evidence of AJOVY® for Migraine Prevention in Children

    Details:

    Ajovy (fremanezumab) is a FDA approved mAb which selectively binds the calcitonin gene-related peptide, it is being investigated for episodic migraine in children and adolescents aged 6-17 years.


    Lead Product(s): Fremanezumab

    Therapeutic Area: Neurology Brand Name: Ajovy

    Study Phase: Phase IIIProduct Type: Large molecule

    Sponsor: Not Applicable

    Deal Size: Not Applicable Upfront Cash: Not Applicable

    Deal Type: Not Applicable July 18, 2024

    blank

    10

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed

    Teva Pharmaceutical Industries

    Israel
    arrow
    BioFlorida Conference
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Lead Product(s) : Fremanezumab

    Therapeutic Area : Neurology

    Highest Development Status : Phase III

    Partner/Sponsor/Collaborator : Not Applicable

    Deal Size : Not Applicable

    Deal Type : Not Applicable

    DEALS_DEV arrow-down

    Teva Announces Phase 3 Evidence of AJOVY® for Migraine Prevention in Children

    Details : Ajovy (fremanezumab) is a FDA approved mAb which selectively binds the calcitonin gene-related peptide, it is being investigated for episodic migraine in children and adolescents aged 6-17 years.

    Brand Name : Ajovy

    Molecule Type : Large molecule

    Upfront Cash : Not Applicable

    July 18, 2024

    blank

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Teva Pharmaceutical Industries and get a quotation

    Teva Pharmaceutical Industries is a supplier offers 301 products (APIs, Excipients or Intermediates).

    Find a price of Nomegestrol Acetate bulk with DMF, CEP offered by Teva Pharmaceutical Industries

    Find a price of Alfacalcidol bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Allopurinol bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Amlodipine Besylate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Amoxicillin Trihydrate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Betamethasone Dipropionate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Bleomycin Sulphate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Calcitriol bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Capecitabine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Carbamazepine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Carvedilol bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Clarithromycin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Clascoterone bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Clopidogrel bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Cyproterone Acetate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Desmopressin Acetate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Diltiazem Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Dorzolamide Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Doxepin Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Drospirenone bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Elagolix Sodium bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Eltrombopag bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Epirubicin Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Etilevodopa bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Etoposide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Fedratinib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Fingolimod Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Fluorouracil bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Fluticasone Furoate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Fluticasone Propionate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Formoterol Fumarate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Furosemide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Gabapentin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Galantamine Hydrobromide bulk with JDMF offered by Teva Pharmaceutical Industries

    Find a price of Gemcitabine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Gemfibrozil bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Glycerol Phenylbutyrate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Ivosidenib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Loperamide Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Losartan Potassium bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Lovastatin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Medroxyprogesterone Acetate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Megestrol Acetate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Memantine Hydrochloride bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Metoprolol Succinate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Metoprolol Tartrate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Midostaurin bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Migalastat bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Mirtazapine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Mitomycin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Mometasone Furoate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Montelukast Sodium bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Mupirocin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Mycophenolate Mofetil bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Nabumetone bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Neratinib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Nifedipine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Nilotinib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Nintedanib Esylate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Nomegestrol Acetate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Olmesartan Medoxomil bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Omeprazole bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Ondansetron Hydrochloride bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Oxaliplatin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Pancuronium Bromide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Pantoprazole Sodium bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Pravastatin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Probenecid bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Quetiapine Hemifumarate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Remimazolam Besylate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Ribociclib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Rimegepant Sulfate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Risdiplam bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Risperidone bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Rivaroxaban bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Rocuronium Bromide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Salbutamol Sulphate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Saxagliptin Hydrochloride bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Simvastatin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Solifenacin Succinate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Tacrolimus bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Tadalafil bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Tafamidis bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Tamoxifen Citrate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Ticlopidine bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Tigecycline bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Tobramycin bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Torsemide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Triamcinolone Acetonide bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Triheptanoin bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Trilaciclib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Tucatinib bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Valbenazine Tosylate bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Valsartan bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Vancomycin Hydrochloride bulk with JDMF offered by Teva Pharmaceutical Industries

    Find a price of Voclosporin bulk with DMF offered by Teva Pharmaceutical Industries

    Find a price of Zoledronic Acid bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Zolpidem Tartrate bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Atorvastatin calcium, Process 4, polymorphic form-I bulk with CEP offered by Teva Pharmaceutical Industries

    Find a price of Diclofenac Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Ergotamine Tartrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Trimethoprim bulk offered by Teva Pharmaceutical Industries

    Find a price of Water bulk offered by Teva Pharmaceutical Industries

    Find a price of Abiraterone Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Aciclovir bulk offered by Teva Pharmaceutical Industries

    Find a price of Afatinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Alclometasone Dipropionate bulk offered by Teva Pharmaceutical Industries

    Find a price of Alendronate Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Amcinonide bulk offered by Teva Pharmaceutical Industries

    Find a price of Amitriptyline bulk offered by Teva Pharmaceutical Industries

    Find a price of Anastrozole bulk offered by Teva Pharmaceutical Industries

    Find a price of Anidulafungin bulk offered by Teva Pharmaceutical Industries

    Find a price of Apixaban bulk offered by Teva Pharmaceutical Industries

    Find a price of Apremilast bulk offered by Teva Pharmaceutical Industries

    Find a price of Aripiprazole bulk offered by Teva Pharmaceutical Industries

    Find a price of Atorvastatin bulk offered by Teva Pharmaceutical Industries

    Find a price of Atosiban bulk offered by Teva Pharmaceutical Industries

    Find a price of Atracurium Besylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Azacitidine bulk offered by Teva Pharmaceutical Industries

    Find a price of Azithromycin bulk offered by Teva Pharmaceutical Industries

    Find a price of Aztreonam bulk offered by Teva Pharmaceutical Industries

    Find a price of Beclomethasone Dipropionate bulk offered by Teva Pharmaceutical Industries

    Find a price of Betamethasone bulk offered by Teva Pharmaceutical Industries

    Find a price of Betamethasone Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Betamethasone Valerate bulk offered by Teva Pharmaceutical Industries

    Find a price of Bicalutamide bulk offered by Teva Pharmaceutical Industries

    Find a price of Bimatoprost bulk offered by Teva Pharmaceutical Industries

    Find a price of Bivalirudin bulk offered by Teva Pharmaceutical Industries

    Find a price of Bortezomib bulk offered by Teva Pharmaceutical Industries

    Find a price of Bromocriptine Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Budesonide bulk offered by Teva Pharmaceutical Industries

    Find a price of Buprenorphine bulk offered by Teva Pharmaceutical Industries

    Find a price of Butorphanol Tartrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Cabazitaxel bulk offered by Teva Pharmaceutical Industries

    Find a price of Cabergoline bulk offered by Teva Pharmaceutical Industries

    Find a price of Calcipotriol bulk offered by Teva Pharmaceutical Industries

    Find a price of Candesartan Cilexetil bulk offered by Teva Pharmaceutical Industries

    Find a price of Carbidopa bulk offered by Teva Pharmaceutical Industries

    Find a price of Carboplatin bulk offered by Teva Pharmaceutical Industries

    Find a price of Carfilzomib bulk offered by Teva Pharmaceutical Industries

    Find a price of Carvedilol Phosphate bulk offered by Teva Pharmaceutical Industries

    Find a price of Caspofungin bulk offered by Teva Pharmaceutical Industries

    Find a price of Ceritinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Chlormadinone Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Cilostazol bulk offered by Teva Pharmaceutical Industries

    Find a price of Cinacalcet Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Cisatracurium Besylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Cisplatin bulk offered by Teva Pharmaceutical Industries

    Find a price of Clobetasol Propionate bulk offered by Teva Pharmaceutical Industries

    Find a price of Clomiphene Citrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Clonazepam bulk offered by Teva Pharmaceutical Industries

    Find a price of Cyclosporine bulk offered by Teva Pharmaceutical Industries

    Find a price of Dabigatran Etexilate Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Darifenacin Hydrobromide bulk offered by Teva Pharmaceutical Industries

    Find a price of Dasatinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Daunorubicin bulk offered by Teva Pharmaceutical Industries

    Find a price of Deferasirox bulk offered by Teva Pharmaceutical Industries

    Find a price of Deferoxamine Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Desloratadine bulk offered by Teva Pharmaceutical Industries

    Find a price of Desonide bulk offered by Teva Pharmaceutical Industries

    Find a price of Desvenlafaxine Fumarate bulk offered by Teva Pharmaceutical Industries

    Find a price of Desvenlafaxine Succinate bulk offered by Teva Pharmaceutical Industries

    Find a price of Dexamethasone bulk offered by Teva Pharmaceutical Industries

    Find a price of Diflorasone bulk offered by Teva Pharmaceutical Industries

    Find a price of Difluprednate bulk offered by Teva Pharmaceutical Industries

    Find a price of Dihydroergocristine bulk offered by Teva Pharmaceutical Industries

    Find a price of Dihydroergotamine Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Dihydroergotoxine Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Diltiazem bulk offered by Teva Pharmaceutical Industries

    Find a price of Dimethyl Fumarate bulk offered by Teva Pharmaceutical Industries

    Find a price of Disodium Pamidronate Pentahydrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Docetaxel bulk offered by Teva Pharmaceutical Industries

    Find a price of Dolutegravir Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Donepezil bulk offered by Teva Pharmaceutical Industries

    Find a price of Doxcercalciferol bulk offered by Teva Pharmaceutical Industries

    Find a price of Doxepin bulk offered by Teva Pharmaceutical Industries

    Find a price of Doxorubicin Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Duloxetine Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Edoxaban Tosylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Eletriptan Hydrobromide bulk offered by Teva Pharmaceutical Industries

    Find a price of Elocalcitol bulk offered by Teva Pharmaceutical Industries

    Find a price of Empagliflozin bulk offered by Teva Pharmaceutical Industries

    Find a price of Eptifibatide bulk offered by Teva Pharmaceutical Industries

    Find a price of Ergonovine Maleate bulk offered by Teva Pharmaceutical Industries

    Find a price of Erlotinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Eszopiclone bulk offered by Teva Pharmaceutical Industries

    Find a price of Etodolac bulk offered by Teva Pharmaceutical Industries

    Find a price of Exenatide bulk offered by Teva Pharmaceutical Industries

    Find a price of Ezetimibe bulk offered by Teva Pharmaceutical Industries

    Find a price of Famciclovir bulk offered by Teva Pharmaceutical Industries

    Find a price of Febuxostat bulk offered by Teva Pharmaceutical Industries

    Find a price of Fidaxomicin bulk offered by Teva Pharmaceutical Industries

    Find a price of Fludarabine Phosphate bulk offered by Teva Pharmaceutical Industries

    Find a price of Fludrocortisone Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Flunisolide bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluocinolone Acetonide bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluocinonide bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluorometholone bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluorometholone Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluoxetine Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluvastatin Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Fluvoxamine bulk offered by Teva Pharmaceutical Industries

    Find a price of Fulvestrant bulk offered by Teva Pharmaceutical Industries

    Find a price of Haloperidol bulk offered by Teva Pharmaceutical Industries

    Find a price of Haloperidol Decanoate bulk offered by Teva Pharmaceutical Industries

    Find a price of Hydrochlorothiazide bulk offered by Teva Pharmaceutical Industries

    Find a price of Ibandronate Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Ibrutinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Icatibant Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Idarubicin Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Imatinib Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Imipramine bulk offered by Teva Pharmaceutical Industries

    Find a price of Imiquimod bulk offered by Teva Pharmaceutical Industries

    Find a price of Ingenol Mebutate bulk offered by Teva Pharmaceutical Industries

    Find a price of Irbesartan bulk offered by Teva Pharmaceutical Industries

    Find a price of Irinotecan Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Lamotrigine bulk offered by Teva Pharmaceutical Industries

    Find a price of Lansoprazole bulk offered by Teva Pharmaceutical Industries

    Find a price of Latanoprost bulk offered by Teva Pharmaceutical Industries

    Find a price of Ledipasvir bulk offered by Teva Pharmaceutical Industries

    Find a price of Leflunomide bulk offered by Teva Pharmaceutical Industries

    Find a price of Letrozole bulk offered by Teva Pharmaceutical Industries

    Find a price of Leuprolide Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Levalbuterol Sulfate bulk offered by Teva Pharmaceutical Industries

    Find a price of Levetiracetam bulk offered by Teva Pharmaceutical Industries

    Find a price of Levofloxacin bulk offered by Teva Pharmaceutical Industries

    Find a price of Linaclotide bulk offered by Teva Pharmaceutical Industries

    Find a price of Linagliptin bulk offered by Teva Pharmaceutical Industries

    Find a price of Linezolid bulk offered by Teva Pharmaceutical Industries

    Find a price of Liraglutide bulk offered by Teva Pharmaceutical Industries

    Find a price of Lixisenatide bulk offered by Teva Pharmaceutical Industries

    Find a price of Lurasidone Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Macitentan bulk offered by Teva Pharmaceutical Industries

    Find a price of Maxacalcitol bulk offered by Teva Pharmaceutical Industries

    Find a price of Methyldopa bulk offered by Teva Pharmaceutical Industries

    Find a price of Methylergonovine Maleate bulk offered by Teva Pharmaceutical Industries

    Find a price of Methylprednisolone Hemisuccinate bulk offered by Teva Pharmaceutical Industries

    Find a price of Methylprednisolone Sodium Succinate bulk offered by Teva Pharmaceutical Industries

    Find a price of Mupirocin Calcium bulk offered by Teva Pharmaceutical Industries

    Find a price of Mycophenolate Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Naproxen bulk offered by Teva Pharmaceutical Industries

    Find a price of Naproxen Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Nateglinide bulk offered by Teva Pharmaceutical Industries

    Find a price of Nefazodone bulk offered by Teva Pharmaceutical Industries

    Find a price of Nicergoline bulk offered by Teva Pharmaceutical Industries

    Find a price of Norgestimate bulk offered by Teva Pharmaceutical Industries

    Find a price of Octreotide Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Olanzapine bulk offered by Teva Pharmaceutical Industries

    Find a price of Ondansetron bulk offered by Teva Pharmaceutical Industries

    Find a price of Paclitaxel bulk offered by Teva Pharmaceutical Industries

    Find a price of Paliperidone bulk offered by Teva Pharmaceutical Industries

    Find a price of Palonosetron bulk offered by Teva Pharmaceutical Industries

    Find a price of Paricalcitol bulk offered by Teva Pharmaceutical Industries

    Find a price of Paroxetine Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Pemetrexed bulk offered by Teva Pharmaceutical Industries

    Find a price of Pentoxifylline bulk offered by Teva Pharmaceutical Industries

    Find a price of Perampanel bulk offered by Teva Pharmaceutical Industries

    Find a price of Percorten bulk offered by Teva Pharmaceutical Industries

    Find a price of Pergolide Mesylate bulk offered by Teva Pharmaceutical Industries

    Find a price of Pioglitazone bulk offered by Teva Pharmaceutical Industries

    Find a price of Pramlintide bulk offered by Teva Pharmaceutical Industries

    Find a price of Pregabalin bulk offered by Teva Pharmaceutical Industries

    Find a price of Raloxifene Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Raltegravir Potassium bulk offered by Teva Pharmaceutical Industries

    Find a price of Ramelteon bulk offered by Teva Pharmaceutical Industries

    Find a price of Regorafenib bulk offered by Teva Pharmaceutical Industries

    Find a price of Rilpivirine bulk offered by Teva Pharmaceutical Industries

    Find a price of Risedronate Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Romidepsin bulk offered by Teva Pharmaceutical Industries

    Find a price of Rosuvastatin Calcium bulk offered by Teva Pharmaceutical Industries

    Find a price of Rotigotine bulk offered by Teva Pharmaceutical Industries

    Find a price of Saxagliptin bulk offered by Teva Pharmaceutical Industries

    Find a price of Sildenafil Citrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Silver Sulfadiazine bulk offered by Teva Pharmaceutical Industries

    Find a price of Silymarin bulk offered by Teva Pharmaceutical Industries

    Find a price of Sitagliptin Phosphate bulk offered by Teva Pharmaceutical Industries

    Find a price of Sofosbuvir bulk offered by Teva Pharmaceutical Industries

    Find a price of Sorafenib bulk offered by Teva Pharmaceutical Industries

    Find a price of Succinate bulk offered by Teva Pharmaceutical Industries

    Find a price of Sunitinib bulk offered by Teva Pharmaceutical Industries

    Find a price of Telmisartan bulk offered by Teva Pharmaceutical Industries

    Find a price of Terguride bulk offered by Teva Pharmaceutical Industries

    Find a price of Teriparatide Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Ticagrelor bulk offered by Teva Pharmaceutical Industries

    Find a price of Timolol Maleate bulk offered by Teva Pharmaceutical Industries

    Find a price of Tiotropium Bromide bulk offered by Teva Pharmaceutical Industries

    Find a price of Tolterodine Tartrate bulk offered by Teva Pharmaceutical Industries

    Find a price of Travoprost bulk offered by Teva Pharmaceutical Industries

    Find a price of Trazodone Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Triamcinolone bulk offered by Teva Pharmaceutical Industries

    Find a price of Triptorelin Pamoate bulk offered by Teva Pharmaceutical Industries

    Find a price of Ulipristal Acetate bulk offered by Teva Pharmaceutical Industries

    Find a price of Umeclidinium Bromide bulk offered by Teva Pharmaceutical Industries

    Find a price of Valacyclovir Hydrochloride bulk offered by Teva Pharmaceutical Industries

    Find a price of Vecuronium Bromide bulk offered by Teva Pharmaceutical Industries

    Find a price of Venlafaxine bulk offered by Teva Pharmaceutical Industries

    Find a price of Vilanterol Trifenatate bulk offered by Teva Pharmaceutical Industries

    Find a price of Vilazodone bulk offered by Teva Pharmaceutical Industries

    Find a price of Warfarin Sodium bulk offered by Teva Pharmaceutical Industries

    Find a price of Zaleplon bulk offered by Teva Pharmaceutical Industries

    Find a price of Zolmitriptan bulk offered by Teva Pharmaceutical Industries

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search